Gravar-mail: DIFFERENCES IN SYMPTOM CLUSTERS IDENTIFIED USING SYMPTOM OCCURRENCE RATES VERSUS SEVERITY RATINGS IN PATIENTS WITH BREAST CANCER UNDERGOING CHEMOTHERAPY